Annual Report 2003 - Nobel Biocare Corporate

NOBEL BIOCARE ANNUAL REPORT 200319Launches of innovative products and concepts2001 2002 2003 2004 – Q1In 2003 NobelBiocare spent EUR13.6 million onR&D and 17 newpatents were filed.R&D ofrevenueSurgicalProsthetic4.5% 4.2% 4.1%◗ Replace SelectTiUnite◗ Brånemark Novum◗ Esthetic abutmentBrånemark System◗ Easy Abutment◗ Procera CrownZirconia◗ Multi-unit angledAbutment◗ Procera ImplantBridge◗ Procera Crown0.4 mm◗ New ProductAssortment (800)• 380 new products• Replace SelectStraight◗ Immediate function◗ Common prostheticoffer◗ Esthetic AbutmentCeram◗ New packaging◗ New surgical kitBrånemark System◗ Stargrip Replace◗ Manual TorqueWrench◗ NobelPerfect◗ Procera PiccoloScanner◗ Procera AbutmentZirconia◗ Soft TissueIntegration◗ NobelDirect◗ 3.0 mm implant◗ NobelPerfectOne-Piece◗ New Temporariesfurther development of compatibleceramic components is of vitalimportance. That is why Nobel Biocarehas a competitive advantage inthe unique Procera technology andits know-how in ceramic materialdevelopment.Immediate FunctionAllowing a patient to leave a clinicwith esthetically and functionallyworking teeth after implant treatmenthas long been the vision of thedental community. Nobel Biocare’sR&D has made that possible.Nobel Biocare is the first companyto receive FDA clearance for immediateloading for all indications inpatients with normal bone quality.Immediate loading is an importantfactor in Nobel Biocare’s strategyaimed at general practitioners. Asdental implants are becoming almostas easy as traditional crown & bridgetherapy, this treatment option willbecome more attractive for bothdentists and patients.As a consequence of the immediateloading concept, Nobel Biocare hasdeveloped the one-piece implantconcept, NobelDirect, launched inearly 2004. NobelDirect is a biologyfriendly one-piece implant specificallydesigned to simplify the use of implantsand ensure long-term estheticsthrough a minimally invasive, flaplessprocedure.Based on NobelDirect, NobelBiocare has additionally developed a3 mm implant that enables singletooth implants for the lower incisorsin the frontal region. This opens up anew indication for implant treatment.Once again, Nobel Biocare is breakingnew territory by becoming thefirst company to get FDA clearancefor an implant that is less than 3.25millimeters.Teeth-in-an-HourThe unique Teeth-in-an-Hourconcept was presented in 2003. Thedentist plans the surgery in advanceusing a computer based planningsystem with the Procera technologyallowing the manufacture and supplyof all the individualized components.Soon after sending the digital imageof the patients jaw to Nobel Biocare,the dentist receives all the componentsand tools for the implant proceduresent directly to his office. With thehelp of drilling templates and theindividually designed components,the dentist can perform both surgeryand prosthetics in one hour and thepatient gets permanent functioningteeth in one visit.During 2003, 100 patients weresuccessfully treated with the method.A global launch will start in 2005.The combination of the planningsystem and Procera technologyprovides extremely high precisionand consequently minimal invasive,flapless surgery can be performed.The process minimizes both pain andswelling for the patient, which incombination with the short treatmenttime, greatly benefits both the dentistand the patient.Future focusR&D and clinical studies will continueto play a vital part of Nobel Biocare’sstrategy to offer patients new teeth.The future focus will be on extendingthe immediate function concept,long-term esthetics and the simplificationof treatment concepts.Clinical publications onimmediate/early loading(Number)50403020100Nobel BiocareStraumann/ITIAstraBiomet/3iSource: Medline database, April 2003